Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1D | P28221 | 1/20 | 0.32 |
| ▸ | HTR1B | P28222 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8227905 | 1.00 | HTR1D (0.32) | HTR1DHTR1BMEN1KMT2A | |
| SCHEMBL13768916 | 1.00 | HTR1D (0.32) | HTR1DHTR1BMEN1KMT2A | |
| SCHEMBL12256715 | 1.00 | HTR1D (0.32) | HTR1DHTR1BMEN1KMT2A | |
| SCHEMBL19733594 | 1.00 | HTR1D (0.32) | HTR1DHTR1BMEN1KMT2A | |
| SCHEMBL22448482 | 1.00 | HTR1D (0.32) | HTR1DHTR1BMEN1KMT2A | |
| SCHEMBL5932373 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL15808481 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL14311915 | 0.95 | HTR1D (0.32) | HTR1DHTR1B | |
| SCHEMBL21142292 | 0.93 | — | — | |
| SCHEMBL8737489 | 0.90 | CA12 (0.35) | HTR1DHTR1BMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230250091-A1 | ASGPR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES | LYCIA THERAPEUTICS, INC. | 2023-08-10 | — | — | US | disclosed |
| EP-3134127-B1 | ANTIBODY-DRUG CONJUGATES WITH HIGH DRUG LOADING | RINAT NEUROSCIENCE CORP (US) | 2020-02-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230250091-A1 | ASGPR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES | ASGR1, LAMP2, FCGR2A | HTR1D 3770/4885HTR1B 2795/4885MEN1 4092/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.